Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01849549 : Neuropsychological and Brain Medical Imaging Study in Patients With Brain Damage
AgesMin: 18 Years Max: 80 Years
Inclusion Criteria:

- age between 18 and 80 years

- french language

- effective contraception for women during the study

- informed consent

- no alcohol intake the day before the exam

- for patients only, focal cerebral lesion (stroke, malformation, tumor, inflammatory,
infectious, traumatic), neonatal pathology or degenerative disease with cognitive

Exclusion Criteria:

- for healthy volunteers: previous neurological history (except non complicated
migraine), previous psychiatric history (except depression with good evolution or
anxiety with maximum one anxiolytic treatment), or severe cranial traumatism

- for patients: vigilance disorders, severe depression or anxiety.

- for both: psychotropic medication other than a hypnotic or an anxiolytic at low doses
without dose modification for at least one month, severe visual or auditory
impairment, patient without judicial or administrative liberty, measure of legal
protection or no capable to express their consent, pregnancy or breastfeeding,
contraindication for MRI, participation in another trial or former involvement in
another trial within one month
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557